1
Exhibit 10.6
AMENDMENT NO. 2 TO LICENSE, DEVELOPMENT
AND SUPPLY AGREEMENT
This Amendment No. 2 to License, Development and Supply Agreement, dated as of
June 5th, 1998, is entered into by and between XXXXXX LABORATORIES , an Illinois
corporation ("Abbott") and CORIXA CORPORATION, a Delaware corporation
("Corixa").
RECITALS
WHEREAS, Corixa and Abbott are parties to that certain License,
Development and Supply Agreement, dated July 24,1997 and amended by Letter
Agreement on May 22, 1998, (the "License Agreement").
WHEREAS, the parties desire to amend the License Agreement, to
modify certain provisions thereof regarding Milestone Payments.
NOW THEREFORE, the parties hereto agree as follows:
AMENDMENT
1. Except as otherwise defined herein, capitalized terms used in this
Amendment shall have the meanings designated in the License
Agreement.
2. Section 3.2 (a) the License Agreement is hereby amended in its
entirety to read as follows:
3.2 (a) Abbott shall pay Corixa [***] within thirty (30)
days following Xxxxxx'x initiation of clinical trials of
Licensed Product.
3. Except as amended hereby, the License Agreement shall continue in
full force and effect in accordance with its terms.
4. This Amendment No. 2 shall be governed by and construed in
accordance with the laws of the state of Washington, regardless of
its or any other jurisdiction's choice of law provisions.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the date first above written.
XXXXXX LABORATORIES CORIXA CORPORATION
By: /s/ Xxxxx X. Xxxxxxx /s/ Xxxx XxXxxx
Its: Corporate Vice President, Diagnostic Xxxx XxXxxx, Chief Operating
Research and Development Officer